Additionally, in women with PCOS presenting metabolic risk factors, higher glypican-4 levels were associated with established cardiovascular disease predictors, including IR, hyperglycemia, hypertension, and dyslipidemia, with a notable emphasis on adipose tissue distribution (26). Here, GPC4 is linked to polycystic ovary syndrome.